您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > PDE10A-IN-2 hydrochloride
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
PDE10A-IN-2 hydrochloride
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
PDE10A-IN-2 hydrochloride图片
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议
50mg电议
100mg电议

产品介绍
PDE10A-IN-2 hydrochloride 是一种有效的,高选择性,具有口服活性的 磷酸二酯酶 10A (PDE10A) 的抑制剂,IC50为 2.8 nM。PDE10A-IN-2 hydrochloride 对其他 PDE 亚型显示出大于 3500 倍的选择性,并可用于肺动脉高压 (PAH) 的研究。
生物活性

PDE10A-IN-2 hydrochloride is a potent, highly selective and orally activephosphodiesterase10A (PDE10A)inhibitor with anIC50of 2.8 nM. PDE10A-IN-2 hydrochloride shows selectivity of >3500-fold against other PDE subtypes. PDE10A-IN-2 hydrochloride can be used for pulmonary arterial hypertension (PAH) research[1].

IC50& Target[1]

PDE10A

2.8 nM (IC50)

体内研究
(In Vivo)

PDE10A-IN-2 hydrochloride (compound 14 3HCL; 2.5 mg/kg; oral administration; daily; for 3 weeks) treatment decreases the typical symptoms of PAH in rats[1].
In Sprague-Dawley rats, the pharmacokinetic study of PDE10A-IN-2 hydrochloride (compound 14 3HCL; 10 mg/kg) shows the oral bioavailability up to ~50%, and the T1/2is 5.2 hours (p.o.), and the Cmaxis 272 ng/mL[1].

Animal Model:Wister rats (6 weeks, 160-180 g) injected with Monocrotaline[1]
Dosage:2.5 mg/kg
Administration:Oral administration; daily; for 3 weeks
Result:Decreased symptoms of the pulmonary arterial hypertension (PAH) rats.
分子量

627.05

性状

Solid

Formula

C33H38Cl3N5O

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

溶解性数据
In Vitro: 

DMSO : 100 mg/mL(159.48 mM;Need ultrasonic)

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM1.5948 mL7.9738 mL15.9477 mL
5 mM0.3190 mL1.5948 mL3.1895 mL
10 mM0.1595 mL0.7974 mL1.5948 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month (sealed storage, away from moisture)。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。